Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes

International Journal of Medical Microbiology

Volumn 304, Issue 3-4, 2014, Pages 464-475

  Lopez Siles, Mireia ^a   Martinez Medina, Margarita ^a   Busquets, David ^b   Sabat Mir, Miriam ^c   Duncan, Sylvia H ^d   Flint, Harry J ^d   Aldeguer, Xavier ^b   Garcia Gil, L Jesús ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c HOSPITAL SANTA CATERINA   (Spain)

^d ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Diagnostics; Escherichia coli; Faecalibacterium prausnitzii; Inflammatory Bowel Disease; Irritable Bowel Syndrome; Prognostics

Indexed keywords

ADALIMUMAB;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CLINICAL FEATURE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DYSBIOSIS; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; RECEIVER OPERATING CHARACTERISTIC; ULCERATIVE COLITIS; ADOLESCENT; BACTERIAL LOAD; COHORT ANALYSIS; GRAM POSITIVE BACTERIUM; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; IRRITABLE BOWEL SYNDROME; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIAL LOAD; COHORT STUDIES; ESCHERICHIA COLI; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84899627277     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.02.009     Document Type: Article

References (50)

1. Ahmed S., Macfarlane G.T., Fite A., McBain A.J., Gilbert P., Macfarlane S. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl. Environ. Microbiol. 2007, 73:7435-7442.
2. Barcenilla A., Pryde S.E., Martin J.C., Duncan S.H., Stewart C.S., Henderson C., Flint H.J. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 2000, 66:1654-1661.
3. Barnich N., Carvalho F., Glasser A.L., Darcha C., Jantscheff P., Allez M., Peeters H., Bommelaer G., Desreumaux P., Colombel J.F., Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 2007, 117:1566-1574.
4. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
5. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
6. Bernstein C.N., Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008, 57:1185-1191.
7. Bernstein C.N., Fried M., Krabshuis J.H., Cohen H., Eliakim R., Fedail S., Gearry R., Goh K.L., Hamid S., Khan A.G., LeMair A.W., Malfertheiner Ouyang Q., Rey J.F., Sood A., Steinwurz F., Thomsen O.O., Thomson A., Watermeyer G. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis. 2010, 16:112-124.
8. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
9. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
10. Cato E.P., Salmon C.W., Moore W.E.C. Fusobacterium prausnitzii (Hauduroy et al.) Moore and Holdeman: emended description and designation of neotype strain. Int. J. Syst. Bacteriol. 1974, 24:225-229.
11. Chassaing B., Etienne-Mesmin L., Bonnet R., Darfeuille-Michaud A. Bile salts induce long polar fimbriae expression favouring Crohn's disease-associated adherent-invasive Escherichia coli interaction with Peyer's patches. Environ. Microbiol. 2013, 15:355-371.
12. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., Colombel J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
13. De Cruz P., Prideaux L., Wagner J., Ng S.C., McSweeney C., Kirkwood C., Morrison M., Kamm M.A. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:372-390.
14. Dreux N., Denizot J., Martinez-Medina M., Mellmann A., Billig M., Kisiela D., Chattopadhyay S., Sokurenko E., Neut C., Gower-Rousseau C., Colombel J.F., Bonnet R., Darfeuille-Michaud A., Barnich N. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 2013, 9:e1003141.
15. Duboc H., Rajca S., Rainteau D., Benarous D., Maubert M.A., Quervain E., Thomas G., Barbu V., Humbert L., Despras G., Bridonneau C., Dumetz F., Grill J.P., Masliah J., Beaugerie L., Cosnes J., Chazouilleres O., Poupon R., Wolf C., Mallet J.M., Langella P., Trugnan G., Sokol H., Seksik P. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013, 62:531-539.
16. Duncan S.H., Hold G.L., Harmsen H.J., Stewart C.S., Flint H.J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2002, 52:2141-2146.
17. Elson C.O., Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes 2012, 3:332-344.
18. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13780-13785.
19. Furet J.P., Firmesse O., Gourmelon M., Bridonneau C., Tap J., Mondot S., Doré J., Corthier G. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 2009, 68:351-362.
20. Huijsdens X.W., Linskens R.K., Mak M., Meuwissen S.G.M., Vandenbroucke-Grauls C.M.J.E., Savelkoul P.H.M. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J. Clin. Microbiol. 2002, 40:4423-4427.
21. Joossens M., Huys G., Cnockaert M., De Preter V., Verbeke K., Rutgeerts P., Vandamme P., Vermeire S. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011, 60:631-637.
22. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
23. Kleessen B., Kroesen A.J., Buhr H.J., Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 2002, 37:1034-1041.
24. Lane D.J. 16S/23S rRNA Sequencing 1991, John Willy and Sons, New York. E. Stackebrandt, M. Goodfellow (Eds.).
25. Lopez-Siles M., Khan T.M., Duncan S.H., Harmsen H.J., Garcia-Gil L.J., Flint H.J. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl. Environ. Microbiol. 2012, 78:420-428.
26. Louis E., Collard A., Oger A.F., Degroote E., El Yafi F.A.N., Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001, 49:777-782.
27. Louis P., Duncan S.H., McCrae S.I., Millar J., Jackson M.S., Flint H.J. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J. Bacteriol. 2004, 186:2099-2106.
28. Manichanh C., Borruel N., Casellas F., Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol. Hepatol. 2012, 9:599-608.
29. Martin H.M., Campbell B.J., Hart C.A., Mpofu C., Nayar M., Singh R., Englyst H., Williams H.F., Rhodes J.M. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93.
30. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L.J. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm. Bowel Dis. 2006, 12:1136-1145.
31. Martinez-Medina M., Aldeguer X., Lopez-Siles M., Gonzalez-Huix F., Lopez-Oliu C., Dahbi G., Blanco J.E., Blanco J., Garcia-Gil L.J., Darfeuille-Michaud A. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm. Bowel Dis. 2009, 15:872-882.
32. Miquel S., Martin R., Rossi O., Bermudez-Humaran L., Chatel J., Sokol H., Thomas M., Wells J., Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 2013, 16:255-261.
33. Mondot S., Kang S., Furet J.P., Aguirre de Carcer D., McSweeney C., Morrison M., Marteau P., Dore J., Leclerc M. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm. Bowel Dis. 2011, 17:185-192.
34. Nikolaus S., Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007, 133:1670-1689.
35. Pineton de Chambrun G., Peyrin-Biroulet L., Lemann M., Colombel J.F. Clinical implications of mucosal healing for the management of IBD. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:15-29.
36. Roberfroid M., Gibson G.R., Hoyles L., McCartney A.L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., Guarner F., Respondek F., Whelan K., Coxam V., Davicco M.J., Leotoing L., Wittrant Y., Delzenne N.M., Cani P.D., Neyrinck A.M., Meheust A. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010, 104(Suppl 2):S1L 63.
37. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
38. Sasaki M., Sitaraman S.V., Babbin B.A., Gerner-Smidt P., Ribot E.M., Garrett N., Alpern J.A., Akyildiz A., Theiss A.L., Nusrat A., Klapproth J.M. Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 2007, 87:1042-1054.
39. Schultsz C., Van Den Berg F.M., Ten Kate F.W., Tytgat G.N., Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999, 117:1089-1097.
40. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Doré J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
41. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005, 19(Suppl A):5-36.
42. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., Grangette C., Vasquez N., Pochart P., Trugnan G., Thomas G., Blottiere H.M., Dore J., Marteau P., Seksik P., Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16731-16736.
43. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., Cosnes J., Corthier G., Marteau P., Dore J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15:1183-1189.
44. Suzuki M.T., Taylor L.T., DeLong E.F. Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5'-nuclease assays. Appl. Environ. Microbiol. 2000, 66:4605-4614.
45. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44-54.
46. Swidsinski A., Loening-Baucke V., Vaneechoutte M., Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 2008, 14:147-161.
47. Weisburg W.G., Barns S.M., Pelletier D.A., Lane D.J. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 1991, 173:697-703.
48. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Jarnerot G., Engstrand L., Tysk C., Jansson J.K. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 2009, 15:653-660.
49. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
50. Yantiss R.K., Odze R.D. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 2006, 48:116-132.